Pre-radiotherapy identification of individual genomic profile to avoid, by resort to customized radiosensitizers, the risk of radioresistance development in patients with localized prostate cancer: author reply
- PMID: 25363875
- PMCID: PMC4277390
- DOI: 10.1259/bjr.20140701
Pre-radiotherapy identification of individual genomic profile to avoid, by resort to customized radiosensitizers, the risk of radioresistance development in patients with localized prostate cancer: author reply
Comment on
-
An arranged marriage for precision medicine: hypoxia and genomic assays in localized prostate cancer radiotherapy.Br J Radiol. 2014 Mar;87(1035):20130753. doi: 10.1259/bjr.20130753. Epub 2014 Feb 3. Br J Radiol. 2014. PMID: 24588670 Free PMC article. Review.
-
Pre-radiotherapy identification of individual genomic profile to avoid, by resort to customized radiosensitizers, the risk of radioresistance development in patients with localized prostate cancer.Br J Radiol. 2015 Jan;88(1045):20140630. doi: 10.1259/bjr.20140630. Br J Radiol. 2015. PMID: 25363844 Free PMC article. No abstract available.
References
-
- Roach MM, Hanks GG, Thames HH, Schellhammer PP, Shipley WU, Sokol GHG, et al. . Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 2006; 65: 965–74. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical